# Tengfu Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tengfu-medical

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Total disclosed funding: $16M
- Latest round: Series A (Mar 21, 2022)
- Investors on record: 7

## About

Established in 2020, Tengfu Medical is a Medical device developer that provides R&D, production and sales of pulmonary embolism intervention medical devices. The company is mainly involved in the field of two main disease areas include pulmonary embolism and deep vein thrombosis. The company has completed 4 rounds of funding as of 2022.

The company specializes in the development of pulmonary artery thrombosis systems. The company self-developed pulmonary artery thrombosis systems has the function of remove bleeding clots, restore blood flow to the pulmonary vessels and save lives.

The company plans to use the series A+ funding for the clinical registration and marketing of interventional devices for acute pulmonary embolism, as well as promoting the development and clinical research of other products for venous thromboembolism treatment.

## Funding rounds

- Series A, Mar 21, 2022, $16M — OrbiMed Advisors, TEDA Venture Capital
- Series A, Aug 2, 2021 — Cowin Capital, K2VC, China Growth Capital, BioTrack Capital
- Angel, Dec 29, 2020 — Vinno Capital

## Investors

- Vinno Capital (https://capitalatlas.ai/funds/vinno-capital) — Angel
- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series A
- K2VC (https://capitalatlas.ai/funds/k2vc) — Series A
- China Growth Capital (https://capitalatlas.ai/funds/china-growth-capital) — Series A
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series A
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A
- TEDA Venture Capital (https://capitalatlas.ai/funds/teda-venture-capital) — Series A